New drug shows promise for kidney disease in early trial
NCT ID NCT03945318
First seen Apr 21, 2026 · Last updated Jun 18, 2026 · Updated 6 times
Summary
This study tested a new drug called BION-1301 in 103 healthy volunteers and adults with IgA nephropathy, a kidney disease. The main goal was to check the drug's safety and how the body processes it. Researchers measured side effects, blood pressure, and kidney function over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Amicis Research Center
Northridge, California, 91324, United States
-
Chris Sholer, P.C.
Oklahoma City, Oklahoma, 73116, United States
-
Colorado Kidney Care, P.C.
Denver, Colorado, 80230, United States
-
Elixia Tampa, LLC
Tampa, Florida, 33618, United States
-
Hallym University Sacred Heart Hospital
Anyang-si, Gyeonggi-do, 14068, South Korea
-
Hanyang University Guri Hostpital
Guri-si, Gyeonggi-do, 11923, South Korea
-
Liberty Research Center
Arlington, Texas, 76012, United States
-
Liberty Research Center
Dallas, Texas, 75230, United States
-
Liverpool University Hospital NHS Foundation Trust
Liverpool, England, L7 8XP, United Kingdom
-
National Health Insurance Service Ilsan Hospital
Goyang-si, Gyeonggi-do, 10444, South Korea
-
Nephrology Associates of Central Florida
Orlando, Florida, 32806, United States
-
New York Nephrology
Clifton Park, New York, 12065, United States
-
PAREXEL Early Phase Clinical Unit
London, HA1 3UJ, United Kingdom
-
Prolato Clinical Research Center
Houston, Texas, 77054, United States
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
-
Soon Chun Hyang University Hospital Cheonan
Cheonan, Chungcheongnam-do, 31151, South Korea
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.